These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2124513)

  • 21. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
    Hellstrand K; Hermodsson S
    Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity.
    Toledano M; Mathiot C; Michon J; Andreu G; Lando D; Brandely M; Fridman WH
    Cancer Immunol Immunother; 1989; 30(1):57-64. PubMed ID: 2513112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
    Itoh K; Platsoucas CD; Balch CM
    Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha.
    Chong AS; Ybarrondo B; Grimes WJ; Hersh EM; Scuderi P
    Cancer Immunol Immunother; 1990; 31(4):255-9. PubMed ID: 2143102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity.
    Mueller EA; Hamprecht K; Anderer FA
    Immunopharmacology; 1989; 17(1):11-8. PubMed ID: 2708032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
    Iho S; Yamamoto T; Takahashi T; Yamamoto S
    J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response.
    Ross ME; Caligiuri MA
    Blood; 1997 Feb; 89(3):910-8. PubMed ID: 9028322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
    Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
    Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
    Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
    Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of NK cells through the 80-kDa TNFR (CD120b).
    Mason AT; McVicar DW; Smith CA; Young HA; Ware CF; Ortaldo JR
    J Leukoc Biol; 1995 Aug; 58(2):249-55. PubMed ID: 7543923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
    Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
    Leung KH
    Cell Immunol; 1989 Oct; 123(2):384-95. PubMed ID: 2507171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suramin inhibits tumor cell cytotoxicity mediated through natural killer cells, lymphokine-activated killer cells, monocytes, and tumor necrosis factor.
    LaPushin R; Totpal K; Higuchi M; Aggarwal BB
    J Clin Immunol; 1994 Jan; 14(1):39-49. PubMed ID: 8132736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation and biological activity of interleukin 12.
    Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
    Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.